Zobrazeno 1 - 10
of 9 681
pro vyhledávání: '"Roy, F."'
Autor:
Huber, G. B. P., Roy, F. A., Koch, L., Tsitsilin, I., Schirk, J., Glaser, N. J., Bruckmoser, N., Schweizer, C., Romeiro, J., Krylov, G., Singh, M., Haslbeck, F. X., Knudsen, M., Marx, A., Pfeiffer, F., Schneider, C., Wallner, F., Bunch, D., Richard, L., Södergren, L., Liegener, K., Werninghaus, M., Filipp, S.
As systems for quantum computing keep growing in size and number of qubits, challenges in scaling the control capabilities are becoming increasingly relevant. Efficient schemes to simultaneously mediate coherent interactions between multiple quantum
Externí odkaz:
http://arxiv.org/abs/2403.02203
Publikováno v:
Archives of Rehabilitation Research and Clinical Translation, Vol 6, Iss 2, Pp 100338- (2024)
Objective: To determine whether chronic pain persists after complete spinal cord injury (SCI). Design: Prospective observational study regarding the outcome of pre-existent chronic pain of inpatients admitted with new clinically diagnosed complete ce
Externí odkaz:
https://doaj.org/article/e749ed94d5194ba5969ffec55ba42bdf
Autor:
Fareed Khawaja, Georgios Angelidakis, Adina Feldman, Vinod Ravi, Eric Woodman, Micah Bhatti, Ella Ariza‐Heredia, Peter Elhajj, Amy Spallone, Ying Jiang, Roy F. Chemaly
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 22006-22022 (2023)
Abstract Background With the rapid evolution of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) pandemic, the development of effective and safe vaccines was of utmost importance to protect vulnerable individuals, including cancer
Externí odkaz:
https://doaj.org/article/6fa7b6d43d4542b58eab3e455971b4cd
Autor:
Ruby Vincy Roy F, Peer Fathima A
Publikováno v:
Heliyon, Vol 10, Iss 6, Pp e27796- (2024)
The paper establishes the effective utilization of North American Electric Reliability Corporation control performance standards for cascaded fractional order controller in dispensing regulation ancillary service to the deregulated structures having
Externí odkaz:
https://doaj.org/article/efc43d62c6c14bee9562ca7c32f45776
Autor:
Tali Shafat, Daniel Grupel, Tzvika Porges, Ran Abuhasira, Ana Belkin, Ofir Deri, Yonatan Oster, Shadi Zahran, Ehud Horwitz, Netanel A. Horowitz, Hazim Khatib, Marjorie Vieira Batista, Anita Cassoli Cortez, Tal Brosh‐Nissimov, Yafit Segman, Linor Ishay, Regev Cohen, Alaa Atamna, Amy Spallone, Roy F. Chemaly, Juan Carlos Ramos‐Ramos, Michal Chowers, Evgeny Rogozin, Noga Carmi Oren, Şiran Keske, Orit Wolfovitz Barchad, Lior Nesher, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV)
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Objectives Hematological malignancy (HM) patients treated with anti‐CD20 monoclonal antibodies are at higher risk for severe COVID‐19. A previous single‐center study showed worse outcomes in patients treated with obinutuzumab compared
Externí odkaz:
https://doaj.org/article/113128f89fa94947817890d9ed48aae7